Edinburgh Research Explorer

Derivation, Characterization, and Stable Transfection of Induced Pluripotent Stem Cells from Fischer344 Rats

Research output: Contribution to journalArticle

  • Mikhail Liskovykh
  • Ilya Chuykin
  • Ashish Ranjan
  • Dina Safina
  • Elena Popova
  • Elena Tolkunova
  • Valentina Mosienko
  • Julia M. Minina
  • Natalia S. Zhdanova
  • John J. Mullins
  • Michael Bader
  • Natalia Alenina
  • Alexey Tomilin

Related Edinburgh Organisations

Open Access permissions

Open

Documents

  • Download as Adobe PDF

    Rights statement: Copyright: © 2011 Liskovykh et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    Final published version, 355 KB, PDF-document

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0027345
Original languageEnglish
Article numbere27345
Pages (from-to)-
Number of pages9
JournalPLoS ONE
Volume6
Issue number11
DOIs
StatePublished - 4 Nov 2011

Abstract

The rat represents an important animal model that, in many respects, is superior to the mouse for dissecting behavioral, cardiovascular and other physiological pathologies relevant to humans. Derivation of induced pluripotent stem cells from rats (riPS) opens the opportunity for gene targeting in specific rat strains, as well as for the development of new protocols for the treatment of different degenerative diseases. Here, we report an improved lentivirus-based hit-and-run riPS derivation protocol that makes use of small inhibitors of MEK and GSK3. We demonstrate that the excision of proviruses does not affect either the karyotype or the differentiation ability of these cells. We show that the established riPS cells are readily amenable to genetic manipulations such as stable electroporation. Finally, we propose a genetic tool for an improvement of riPS cell quality in culture. These data may prompt iPS cell-based gene targeting in rat as well as the development of iPS cell-based therapies using disease models established in this species.

Download statistics

No data available

ID: 2827947